CYTODRIVE Trademark

Trademark Overview

On Friday, June 14, 2019, a trademark application was filed for CYTODRIVE with the United States Patent and Trademark Office. The USPTO has given the CYTODRIVE trademark a serial number of 88474086. The federal status of this trademark filing is REGISTERED as of Tuesday, February 16, 2021. This trademark is owned by Obsidian Therapeutics, Inc.. The CYTODRIVE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the field of cell and gene therapies; pharmaceutical research and development in the field of regulation of cellular signaling molecules
cytodrive

General Information

Serial Number88474086
Word MarkCYTODRIVE
Filing DateFriday, June 14, 2019
Status700 - REGISTERED
Status DateTuesday, February 16, 2021
Registration Number6273555
Registration DateTuesday, February 16, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements

Goods and ServicesPharmaceutical research and development in the field of cell and gene therapies; pharmaceutical research and development in the field of regulation of cellular signaling molecules
Pseudo MarkCYTO DRIVE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 27, 2019
Primary Code042
First Use Anywhere DateThursday, July 25, 2019
First Use In Commerce DateThursday, July 25, 2019

Trademark Owner History

Party NameObsidian Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138
Party NameObsidian Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events

Event DateEvent Description
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 18, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, November 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 16, 2021REGISTERED-PRINCIPAL REGISTER
Friday, January 15, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 14, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, December 27, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 9, 2020USE AMENDMENT FILED
Sunday, December 27, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 9, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Tuesday, June 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020EXTENSION 1 GRANTED
Friday, May 29, 2020EXTENSION 1 FILED
Friday, May 29, 2020TEAS EXTENSION RECEIVED
Tuesday, December 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, September 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 6, 2019ASSIGNED TO EXAMINER
Thursday, June 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 18, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

cytodrive pharmaceutical development field research signaling molecules cellular gene cell therapies